| 【Fixed Income Research】EVERRE – How far can the spill-over reach? |
| 【Company Research】Yum China (9987 HK) – Guidance was in-line but coffee will accelerate |
| 【Company Research】I-Mab BioPharma (IMAB US) – CD73 confirmed as a promising target for cancer immunotherapy |
| 【Company Research】CG Services (6098 HK) – Acquisition of R&F Property Services: quick wrap up is the key |
| 【Sector Research】China Express Delivery Sector – Easing ASP pressure in Aug to drive sector rebound |
| 【Company Research】HUTCHMED (13 HK) – A home-grown, global-facing Biopharma |
| 【Company Research】Yum China (9987 HK) – Another hit taken, but stay mid-term positive |
| 【Sector Research】China Technology Sector – Apple Launch Event: iPhone 13/Watch 7 largely inline; no new AirPods 3 slightly disappointing |
| 【Company Research】AK Medical (1789 HK) – Big winner in National VBP |
| 【Sector Research】China Property Sector – NBS Aug data deteriorated rapidly |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2021 CMB International Capital Corporation Limited. All rights reserved.
